These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 570121)

  • 1. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
    Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
    [No Abstract]   [Full Text] [Related]  

  • 2. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
    Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
    Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new dopamine agonists that are long acting in vivo but short acting in vitro.
    Grossman A; Yeo T; Delitala G; Hathway NR; Besser GM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):595-9. PubMed ID: 7226572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ergocryptine on prolactin secretion druing concurrent pregnancy and lactation in the rat.
    Flint DJ; Ensor DM
    J Reprod Fertil; 1979 Jul; 56(2):691-6. PubMed ID: 582608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
    Russell JA; Harrison DJ; McNeilly AS
    J Endocrinol; 1981 Apr; 89(1):91-8. PubMed ID: 6894307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
    Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
    Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in rats.
    Formelli F; Zaccheo T; Di Salle E; Ornati G; Di Marco A
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1545-51. PubMed ID: 6416848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
    Hooley RD; Fell LR; Findlay JK
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):722-7. PubMed ID: 411304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect evidences of prolactin involvement in precocious puberty induced by hypothalamic lesions in female rats.
    Alvarez EO; Hancke JL; Advis JP
    Acta Endocrinol (Copenh); 1977 May; 85(1):11-7. PubMed ID: 577071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
    Floss HG; Cassady JM; Robbers JE
    J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of lactation in rabbits by 2-Br-alpha-Ergokryptine-mesilate (CB154).
    Flückiger E; Billeter E; Wagner HR
    Arzneimittelforschung; 1976; 26(1):51-3. PubMed ID: 947176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 19. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibitors of pituitary prolactin release on testicular cholesterol stores, seminal vesicles weight, fertility, and lactation in mice.
    Bartke A
    Biol Reprod; 1974 Oct; 11(3):319-25. PubMed ID: 4480365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.